Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Next Pharmaceuticals

Next Pharmaceuticals?uq=UG6efJS6
1997 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer and manufacturer of herbal supplement ingredients. The company develops natural raw materials for the dietary supplement, food and beverage industries and operates various brands which include Relora, Sytrinol, Seditol and Nexrutine.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Primary Office
  • 360 Espinosa Road
  • Salinas, CA 93907
  • United States

Next Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Next Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Next Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Charles Kosmont Co-Founder, Chief Executive Officer and Chairman